Cargando…

Oral Immunotherapy in Food Allergy: Where Are We Now?

Food allergy (FA) has become more prevalent and problematic in the last 2 decades, and it poses important individual, social, and economic burdens. Besides treating reactions induced by accidental exposure and periodic evaluation for acquiring natural tolerance, the primary management approach is st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özdemir, Pınar Gökmirza, Sato, Sakura, Yanagida, Noriyuki, Ebisawa, Motohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079524/ https://www.ncbi.nlm.nih.gov/pubmed/37021501 http://dx.doi.org/10.4168/aair.2023.15.2.125

Ejemplares similares

Long-term outcomes of oral immunotherapy for anaphylactic egg allergy in children
por: Sasamoto, Koki, et al.
Publicado: (2022)

Hospital oral food challenge tests in the coronavirus disease 2019 pandemic: A nationwide survey
por: Yanagida, Noriyuki, et al.
Publicado: (2023)

Regular intake of cow’s milk with oral immunotherapy improves statures of children with milk allergies
por: Emura, Shigehito, et al.
Publicado: (2020)

Heated egg yolk challenge predicts the natural course of hen’s egg allergy: a retrospective study
por: Okada, Yu, et al.
Publicado: (2016)

Food allergy and anaphylaxis – 2059. Mild symptoms induced by oral food challenge are not always associated with failed challenge results
por: Miura, Taro, et al.
Publicado: (2013)

Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Correction: Do Longer Intervals between Challenges Reduce the Risk of Adverse Reactions in Oral Wheat Challenges?
por: Yanagida, Noriyuki, et al.
Publicado: (2015)

Prevention of allergies in childhood – where are we now?
por: Ahrens, B., et al.
Publicado: (2017)

Food allergy and anaphylaxis – 2054. Easy-to-use severity grading system for treatment of symptoms induced by oral food challenge
por: Yanagida, Noriyuki, et al.
Publicado: (2013)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Immunotherapy and Hepatocellular Cancer: Where Are We Now?
por: Valery, Marine, et al.
Publicado: (2022)

Safe egg yolk consumption after a negative result for low‐dose egg oral food challenge
por: Yanagida, Noriyuki, et al.
Publicado: (2020)

A randomized trial of oral immunotherapy for pediatric cow's milk‐induced anaphylaxis: Heated vs unheated milk
por: Nagakura, Ken‐ichi, et al.
Publicado: (2020)

Peptide-based immunotherapy in lupus: Where are we now?
por: P. Singh, Ram, et al.
Publicado: (2023)

Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts
por: Borres, Magnus P., et al.
Publicado: (2022)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)

75 Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
por: Ogura, Kiyotake, et al.
Publicado: (2012)

Food allergy prevention: Where are we in 2023?
por: Venter, Carina, et al.
Publicado: (2023)

Food allergy and anaphylaxis – 2056. Clinical cross-reactivity of major food allergens among children
por: Hasegawa, Miho, et al.
Publicado: (2013)

Immunotherapy after liver transplantation: Where are we now?
por: Au, Kin Pan, et al.
Publicado: (2021)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Oral microbiome and peri-implant diseases: where are we now?
por: Pokrowiecki, Rafał, et al.
Publicado: (2017)

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series
por: Hara, Shuhei, et al.
Publicado: (2023)

Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
por: Varrone, Francesca, et al.
Publicado: (2021)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Where are we now?
Publicado: (1977)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Mouse Models for Food Allergies: Where Do We Stand?
por: Schülke, Stefan, et al.
Publicado: (2019)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
por: Dixon-Douglas, Julia, et al.
Publicado: (2023)

Oral and sublingual immunotherapy for food allergy
por: Le, Uyenphuong H, et al.
Publicado: (2014)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Accidental ingestion of food allergens: A nationwide survey of Japanese nursery schools
por: Yanagida, Noriyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vpjk596g1b5lng75nr2ggg34j0